A, Zimmermann WH. Preservation of left ventricular function and morphology in volume-loaded versus volume-unloaded heterotopic heart transplants. Am J Physiol Heart Circ Physiol 305: H533-H541, 2013. First published June 14, 2013 doi:10.1152/ajpheart.00218.2013.-Total mechanical unloading of the heart in classical models of heterotopic heart transplantation leads to cardiac atrophy and functional deterioration. In contrast, partial unloading of failing human hearts with left ventricular (LV) assist devices (LVADs) can in some patients ameliorate heart failure symptoms. Here we tested in heterotopic rat heart transplant models whether partial volume-loading (VL; anastomoses: aorta of donor to aorta of recipient, pulmonary artery of donor to left atrium of donor, superior vena cava of donor to inferior vena cava of recipient; n ϭ 27) is superior to the classical model of myocardial unloading (UL; anastomoses: aorta of donor to aorta of recipient, pulmonary artery of donor to inferior vena cava of recipient; n ϭ 14) with respect to preservation of ventricular morphology and function. Echocardiography, magnetic resonance imaging, and LV-pressurevolume catheter revealed attenuated myocardial atrophy with ϳ30% higher LV weight and better systolic contractile function in VL compared with UL (fractional area shortening, 34% vs. 18%; maximal change in pressure over time, 2,986 Ϯ 252 vs. 2,032 Ϯ 193 mmHg/s). Interestingly, no differences in fibrosis (Picrosirus red staining) or glucose metabolism (2-[18F]-fluoro-2-deoxy-D-glucose-PET) between VL and UL were observed. We conclude that the rat model of partial VL attenuates atrophic remodelling and shows superior morphological as well as functional preservation, and thus should be considered more widely as a research model. heterotopic heart transplantation; cardiac atrophy; left ventricular function; rat; left ventricular assist devices MECHANICAL UNLOADING OF FAILING hearts by left ventricular (LV) assist devices (LVADs) is increasingly used in end-stage heart failure patients as a bridge to transplantation, bridge to recovery, or destination therapy (15). LVAD support can improve cardiac performance and quality of life in some (4 -10%) patients with end-stage heart failure (17, 20, 23, 28) . However, prolonged LVAD support can also have detrimental effects including pronounced cardiomyocyte atrophy (26), impaired calcium handling (14, 29) , and an increase in left ventricular collagen content during LVAD support (17). To gain a better understanding of the mechanisms underlying mechanical unloading, rodent models of heterotopic transplantation have been used (1, 5-7, 12-14, 18, 26, 29, 31, 32). The classical heterotopic abdominal heart transplantation model in rats with complete unloading, originally described by Ono and Lindsey (25), is so far the most commonly used model to simulate the effects of mechanical unloading. Although some studies have indeed shown that this nonworking model might be suitable to examine some aspects of cardiac atrophic remodeling (5, 6, 12), this approach has considerable limitations, such as substantial atrophy and functional deterioration. To circumvent these limitations, alternative surgical techniques, including placement of an isovolumic balloon into the left ventricle (16), generation of an aortic valve incompetence (18), and anastomosis of the left atrium to the ligated recipients' inferior vena cava (7) as well as atrioseptectomy and removal of the tricuspid valve (33) have been developed to load the left ventricle. Asfour and colleagues (1) proposed another approach with more physiological blood flow and without the need to destroy intracardiac structures or to insert foreign material. However, a detailed comparison of the classical Ono and Asfour models by making use of high-end imaging technologies (high-resolution ultrasound, magnetic resonance imaging, positron emission tomography) and hemodynamic assessment (pressure-volume analyses with Millar-catheterization) to scrutinize morphology, mechanical function, and metabolisms in volume-unloaded (UL) versus volume-loaded (VL) has to our knowledge not been performed, so far. Our data show that LV volume-loading attenuates cardiac atrophy and preserves LV function over a 4-wk duration, without influencing glucose metabolism or fibrotic remodelling.
MECHANICAL UNLOADING OF FAILING hearts by left ventricular (LV) assist devices (LVADs) is increasingly used in end-stage heart failure patients as a bridge to transplantation, bridge to recovery, or destination therapy (15) . LVAD support can improve cardiac performance and quality of life in some (4 -10%) patients with end-stage heart failure (17, 20, 23, 28) . However, prolonged LVAD support can also have detrimental effects including pronounced cardiomyocyte atrophy (26) , impaired calcium handling (14, 29) , and an increase in left ventricular collagen content during LVAD support (17) . To gain a better understanding of the mechanisms underlying mechanical unloading, rodent models of heterotopic transplantation have been used (1, 5-7, 12-14, 18, 26, 29, 31, 32) . The classical heterotopic abdominal heart transplantation model in rats with complete unloading, originally described by Ono and Lindsey (25) , is so far the most commonly used model to simulate the effects of mechanical unloading. Although some studies have indeed shown that this nonworking model might be suitable to examine some aspects of cardiac atrophic remodeling (5, 6, 12) , this approach has considerable limitations, such as substantial atrophy and functional deterioration. To circumvent these limitations, alternative surgical techniques, including placement of an isovolumic balloon into the left ventricle (16) , generation of an aortic valve incompetence (18) , and anastomosis of the left atrium to the ligated recipients' inferior vena cava (7) as well as atrioseptectomy and removal of the tricuspid valve (33) have been developed to load the left ventricle. Asfour and colleagues (1) proposed another approach with more physiological blood flow and without the need to destroy intracardiac structures or to insert foreign material. However, a detailed comparison of the classical Ono and Asfour models by making use of high-end imaging technologies (high-resolution ultrasound, magnetic resonance imaging, positron emission tomography) and hemodynamic assessment (pressure-volume analyses with Millar-catheterization) to scrutinize morphology, mechanical function, and metabolisms in volume-unloaded (UL) versus volume-loaded (VL) has to our knowledge not been performed, so far. Our data show that LV volume-loading attenuates cardiac atrophy and preserves LV function over a 4-wk duration, without influencing glucose metabolism or fibrotic remodelling.
METHODS

Animal models of heterotopic abdominal heart transplantation.
Hearts from 41 adult male Wistar rats (Charles River, Sulzfeld, Germany) were perfused (in situ) with cardioplegic solution (St. Thomas' cardioplegia) and explanted. Of these, 14 were abdominally transplanted under UL conditions (anastomoses: ascending aorta of donor to abdominal aorta of recipient, pulmonary artery of donor to inferior vena cava of recipient) (Fig. 1A) according to Ono and Lindsey (25) and under VL conditions (anastomoses: ascending aorta of donor to abdominal aorta of recipient, donor's pulmonary artery to left atrium of the same heart, superior vena cava of donor to inferior vena cava of recipient) (Fig. 1B) according to Asfour et al. (1) . At the time point of and for three days after the operation animals received analgesia with 0.025 mg/kg body weight (BW) buprenorphine and antimicrobial treatment with 2,000 mg/kg BW amoxicillin. Furthermore, experimental animals received 5 mg/kg BW cyclosporine and 2 mg/kg BW methylprednisolone daily until the end of the study. To avoid thrombus formation, 1 mg/kg BW enoxaparin was administered daily subcutaneously for 14 days. All experiments were conducted in in situ image after implantation; middle: schematic diagram of the implanted heart, with red arrows indicating the direction of blood flow; right: flow chart of study protocol). Before implantation the right superior and inferior Vv. cavae (a) were ligated. The left superior V. cava and the pulmonary hili (b) were subsequently ligated en bloc. Myocardial perfusion via the coronary arteries of the donor's heart was provided by an anastomosis of the donor's ascending aorta (c) to the recipient's abdominal aorta (d). Blood drained from the coronary sinus was ejected via the donor's pulmonary trunk (e) into the recipient's V. cava inferior (f). B: partially volume-loaded (VL) model (left: in situ image after implantation; middle: schematic diagram of the implanted heart, with red arrows indicating the direction of blood flow; right: flow chart of study protocol). Blood enters the right ventricle (RV) via the recipient's V. cava inferior (f) and the donor heart's V. cava superior (b). A connection between the RV and LV is generated by an anastomosis of the pulmonary trunk (e) to the left atrium (LA; g). Blood from the LV is ejected against the systemic blood pressure via the donor heart's ascending aorta (c) into the recipient's abdominal aorta (d). C: wet weights of donor hearts before transplantation (baseline) and of orthotopic and heterotopic hearts 4 wk after transplantation. *P Ͻ 0.05 vs. heterotopic; n ϭ 11-17/group. tation and on orthotopic and heterotopic hearts at days 1, 7, 14, and 28 after transplantation. Animals were anesthetized with isoflurane (1.5-2 vol%) during the procedure. The long axes of the orthotopic and heterotopic hearts were defined by a plane including the aortic valve and the tip of the apex. The short axis was analyzed at the mid-papillary level after turning the scan-head by 90°. LV weight was calculated by the area-length method (8) . Heart rates were calculated from a short-axis M-mode.
MRI. We performed MRI under volatile isoflurane (1.5-2 vol%) anesthesia with a Bruker 4.7T BioSpec System using Intragate (9), a Fast Low Angle Shot (FLASH) gradient echo sequence. This self-gated cardiac protocol using an in-slice navigator echo allowed for CINE MRI separately from the orthotopic and the heterotopic hearts. Because the k-space reconstruction was driven by the navigator information derived from the acquisition volume, this recording did not rely on echocardiography-gating, which was, in addition, difficult to achieve with uncoordinated signals stemming from the heterotopic and the orthotopic hearts. With the Intragate FLASH sequence 15 to 16 short axis slices (1.08 mm) with a field of view (FOV) 6 ϫ 6 cm, matrix 128 ϫ 128, TE (echo time) ϭ 5.5 ms, TR (repetition time) ϭ 8.9 ms, flip angle ϭ 10 degrees were acquired. Initially, we obtained a longitudinal view of the heart for orientation purposes. Subsequently, we subjected data sets to offline analysis with manual segmentation of the heart contours.
LV catheterization. Pressure-volume loops were recorded under isoflurane (2 vol%) anesthesia with a Millar 2 Fr catheter (model SPR-838) connected to Aria/PowerLab data-acquisition hardware (Millar/PowerLab). Volume calibration was performed with heparinized blood. To record pressure-volume loops in orthotopic hearts, the catheter was inserted into the LV cavity via the right main carotid artery and the ascending aorta. Subsequently, the abdominal cavity was opened and the apex of the heterotopic heart was cannulated with a 27 G cannula. Immediately, the pressure-volume catheter was inserted via the apex. We analyzed all data offline with PVAN 3.2 software (Millar).
PET. PET was performed with a Mosaic small-animal PET system (Philips) (11) . This system provides spatial resolution of about 3 mm full-width-at-half-maximum, which is adequate for heart imaging in the rat (10) . Four weeks after heterotopic heart transplantation, freshly synthesized 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) was injected into the tail vein of rats anesthetized with isoflurane (1.5-2 vol%). Blood glucose levels were monitored and kept above 130 mg/dl by intraperitoneal injection of 20% glucose-solution. PET imaging was started within 60 min after FDG injection. The mean signal-intensity per pixel was quantified by tracing the LV area of the orthotopic and heterotopic hearts of the same animal in a transversal DICOM image using the ImageJ software.
Histological assessment of cardiac fibrosis. Cardiac fibrosis was determined by Picrosirius red staining of cross sections of orthotopic and heterotopic hearts in five animals from the VL group and in four animals from the UL group, and quantified using the Axiovision Measure plus software package (Zeiss, Germany). The fibrotic area was analyzed in five visual fields of the left myocardium in each heart. Care was taken to exclude pericardium and major vessels. Hematoxylin and eosin (H&E) staining was performed according to standard protocols.
PCR. The quantitative PCR measurements were done in LV myocardial tissue. RNA was isolated from ϳ30 mg frozen ventricular heart tissue (SV Total RNA Isolation System Kit; Promega), and 1 g RNA per sample were taken to generate cDNA (High Capacity cDNA Reverse Transcription Kits; Applied Biosystems) according to the manufacturer's guidelines. The relative amounts of transcripts were analyzed by quantitative PCR (SYBR Green/ROX qPCR Master Mix; Fermentas) in a ABI PRISM 7900HT Sequence Detection System (Applied Biosystems). Glut1, Glut4, and Col1a1 transcript abundance was normalized to GAPDH. The following forward/reverse primers were used: Glut1: CATCGTCGTTGGGATCCTTA/AGACTTGTGGCCTCTACTGCTCA (5); Glut4: CCCCCGATACCTCTACAT/CTGGGCTGATGTGTCT-GATGC (5); Col1a1: TGGTCCTCAAGGTTTCCAAG/GATGAT-GGGGAAGCTGGTAA; and GAPDH: AACTCCCTCAAGATTGT-CAGCA/CATCACTGCCACTCAGAAGACT.
Statistical analysis. All data are given as means Ϯ SE. For statistical analyses, two-sided, unpaired Student's t-test was used. Significant differences between groups were accepted if P Ͻ 0.05. 
RESULTS
Study protocol and weight of VL and UL hearts. Heterotopic heart transplantation was performed according to Ono and Lindsey (25) (UL; n ϭ 14; Fig. 1A ) and Asfour et al. (1) (VL; n ϭ 27; Fig. 1B) . Out of the 41 recipient animals, nine died within 1 wk after the surgical procedure [7 in the VL group (26%); 2 in the UL group (14%)]. Three animals (11%) in the VL group developed echocardiographically visible LVthrombi at one day after transplantation despite anticoagulation and were excluded from the study. At 4 wk after transplantation heterotopic heart weights were reduced as compared with heart weight at the time of implantation (baseline) and also as compared with the orthotopic hearts at 4 wk. Notably, UL hearts showed a significantly lower heart weight compared with VL hearts (Fig. 1C) .
LV morphology and function in VL and UL by echocardiography and MRI.
To analyze the morphological and functional changes over the 4 wk time course of the study, echocardiography was performed before donor heart explantation (day Ϫ1) and at days 1, 7, 14, and 28 after implantation (Fig. 2A) . The anterior wall thickness (AWThs) in systole of UL decreased rapidly within the first day after transplantation and continued to decrease during the following 4 wk. In contrast, AWThs in VL showed a significant decline only at 4 wk after transplantation (Fig. 2B) . Interestingly, the anterior wall thickness in diastole (AWThd) showed an initial increase in both groups. Four weeks after transplantation AWThd of UL was markedly lower than that in the orthotopic hearts, whereas AWThd of VL was similar to that of orthotopic hearts (Fig.  2C) . The LV inner diameter in systole increased directly after the transplantation, but was similar to the orthotopic hearts up to 4 wk (Fig. 2D) . In contrast, the LV inner diameter in diastole decreased rapidly in VL and UL and reached a plateau after 7 days (Fig. 2E) . Fractional area shortening (FAS; Fig. 2F ) and anterior wall thickening fraction (AWThF; Fig. 2G ), parameters of global and regional cardiac function, respectively, showed a less pronounced decline in VL compared with UL during the whole time course of the study. LV weight of UL decreased rapidly within the first seven days after transplantation; VL showed a less pronounced decrease (Fig. 2H) . Interestingly, after an initial drop of the heterotopic hearts' beating rate as a result of denervation, the beating rate of the VL hearts increased steadily during the following 4 wk (Fig. 2I) . To verify the results of the echocardiographic measurements, we used cardiac MRI (Fig. 3A) . In comparison with echocardiography, FAS of VL was overestimated by MRI. This was very likely due the difficulty to provide voxel information precisely at end systole. However, the proportional differences between FAS in VL and UL were similar in the echocardiographic recordings ( Fig. 2F) and MRI (Fig. 3B ). AWThF derived from MRI ( Fig. 3B ) also confirmed the echocardiographically recorded data (Fig. 2G) .
Analysis of LV function by pressure-volume catheter.
To complement the echocardiography and MRI data we performed pressure-volume catheterization in orthotopic and heterotopic hearts before euthanization at 4 wk after transplantation (Fig. 4A) . The maximum stroke volume confirmed the functionality of the surgical model for partial unloading used in this study (orthotopic hearts: 335 Ϯ 17 l, heterotopic VL: 136 Ϯ 20 l). Interestingly, UL also showed a maximum stroke volume of 53 Ϯ 9 l (Fig. 4B) , presumably as a result of aortic valve insufficiency in UL, which was not detected in VL (Fig. 4A) . In contrast to that in UL, systolic pressure in VL was not compromised and similar to orthotopic hearts (Fig. 4C) . Diastolic pressures were similar in all experimental groups (Fig. 4D) . Maximal positive (dP/dt max ) and negative derivative of intraventricular pressure (dP/dt min ) as indicators of LV contraction and relaxation capacity, respectively, showed a less pronounced deterioration in VL compared with UL (Fig. 4, E and F) .
Analysis of cardiac glucose metabolism and fibrosis. To gain insight into the metabolic changes after partial and complete volume unloading, we analyzed glucose uptake of heterotopic hearts in comparison with orthotopic hearts by injection of 18F-fluoro-deoxy-glucose (FDG) and subsequent detection of photon-emitting decay events by PET (Fig. 5A) . The average signal intensity of the heterotopic heart was correlated to that of the orthotopic heart of the same animal. Both VL and UL showed a similar reduction in FDG uptake 4 wk after transplantation to approximately one third of orthotopic hearts (Fig.  5B) . Furthermore, by using quantitative PCR we detected a similar increase of the fetal form of the glucose transporter (GLUT 1) in both groups of heterotopic transplanted hearts, whereas the expression of the adult form (GLUT 4) did not change in comparison with heterotopic hearts (Fig. 5C ). Similarly, both groups showed a comparable increase of cardiac fibrosis 4 wk after transplantation as determined histologically by H&E and Picrosirius red staining (Fig. 6 , A-C) and quantitative PCR for collagen type I ␣-1 (Col1a1; Fig. 6D ).
DISCUSSION
In this study we performed a direct comparison of the classical Ono and Lindsey model of LV unloading (25) with the volume-loaded heterotopic heart transplantation model described by Asfour and colleagues (1) . The rationale for our study was to assess whether morphological and functional deterioration in the VL model would be less pronounced as compared with the UL model. For this we chose a study design involving high-end imaging (serial echocardiography over 4 wk, MRI, and FDG-PET) and LV-pressure-volume catheterization supported by morphological and molecular studies. The finding that VL attenuates myocardial atrophy and preserves cardiac function compared with UL may have important implications for future applications of the heterotopic heart transplant model not only for studies of myocardial reverse remodelling/atrophy but also, for example, for tissue engineeringbased LV restoration after scar tissue extraction (34, 35) , which we find difficult to perform in orthotopic position in a rodent heart (own unpublished experience). We chose a study duration of 4 wk based on earlier work on heterotopic transplantation of infarcted rat hearts under volume-unloaded conditions; here the optimal duration of unloading with regard to stably maintained cardiac function, gene expression, and cardiomyocyte hypertrophy was defined as less than 4 wk (26) . To analyze longitudinal changes of function and morphology in VL and UL, we performed echocardiography at regular intervals and confirmed the data by MRI and pressure-volume analyses via left heart catheterization. Functional parameters like FAS and AWThF as well as LV diameters stabilized after 7 days in both models. In contrast, LV wall thicknesses in systole and diastole declined progressively after heterotopic transplantation in both groups. However, the decline in the VL model was delayed with diastolic anterior wall thickness being similar in heterotopically transplanted and orthotopic hearts until the end of the study period. This together with stable LV dimensions, FAS, and AWThF suggests that continuous LV atrophy in VL and UL with reduced but stable LV function is an adaptation to partial and complete volume-unloading. The drop in LV function may at least in part be attributable to denervation of the VL and UL hearts, resulting in subphysiological heart rates (353 vs. 269 beats/min in ortho-vs. heterotopic hearts) (27) as well as the nonphysiological location in the abdomen. Given the similar heart rate and environment of the heterotopically transplanted hearts, we conclude that the difference in function and atrophy must be attributed to the difference in volume load.
Pressure-volume loop recordings provided clear evidence for differences in volume output in VL and UL hearts (136 vs. 53 l). Here it is important to note that the LV output was, compared with the orthotopic hearts, reduced by 60% and 85% in VL and UL hearts, respectively. The output reduction in VL was very similar to what can be achieved with the recently developed miniaturized CircuLite LVAD-devices (22) . Systolic pressure in VL was similar to orthotopic hearts. Interestingly, in the study by Asfour and colleagues (1) using the same VL model the systolic pressure developed by the heterotopically implanted hearts was markedly lower than in our study. This might be explained by the shorter study duration (2 vs. 4 wk) and/or a different rats strain (Lewis vs. Wistar rats) in the Asfour study.
Normally, increased cardiac work rapidly stimulates cardiac glucose utilization (4) and glucose uptake (30) . We anticipated that VL with higher stroke volumes and systolic pressures, and thus higher cardiac work would show higher glucose metabolism. However, we found a similarly decreased glucose uptake measured by FDG-PET in the VL and UL models. We minimized confounding effects of inter-individual differences in FDG-dose and insulin-mediated cellular glucose-uptake variability by using the orthotopic heart as an internal standard. Consistent with the PET-data, quantitative PCR of glucose transporter revealed that there was a similar increase in GLUT 1 (fetal form) expression in both groups of heterotopic hearts, whereas there was no change in expression of GLUT4 (adult form) compared with orthotopic hearts. Cardiac glucose uptake typically decreases during prolonged ischemia (2) . However, contrasting a prior study (31), we did not see apparent signs of chronic ischemic damage, e.g., ventricular dilatation. Consistent with our data, in a study of heterotopically transplanted rat hearts, volume-loading of the left ventricle by vena cava inferior ligation did not show effects on cardiac energy metabolism (7) .
Conflicting data exists with regard to collagen content in LVAD-treated hearts, with some studies reporting a decrease (3, 21) and others showing an increase (17) . At least some increase of the relative but not the absolute collagen content can be explained by atrophy of the cardiomyocytes in volumeunloaded hearts (19, 26) . Histological analyses of explanted hearts in our study revealed a similar increase in collagen content in both groups despite reduced cardiac atrophy in VL. Consistently, we could not detect a significant difference in collagen 1a1 expression between VL and UL heterotopic hearts.
Mechanical support devices were originally constructed to totally unload the failing heart. Our study suggests that complete in contrast with partial volume-unloading is detrimental for heart function and morphology. Whether this effect of partial volume-unloading is persistent in failing hearts has to be evaluated in further studies. The interpretation of our study with regard to the utility of the VL model as experimental surrogate for clinical LVAD-based unloading of the heart is limited, because we used primarily nonfailing hearts for heterotopic transplantation. So far, heterotopic transplantation of hearts subjected to coronary artery ligation has been performed under UL conditions (24, 26) , and it will be the next challenge to establish similar conditions in the VL model. A model of VL failing hearts may be particularly attractive not only for studies of reverse remodelling but also for studies attempting to test tissue engineering technologies for heart repair (34, 35) . 
